Map2K1 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
| Mitogen-Activated Protein Kinase Kinase 1 | |
|---|---|
| Gene Symbol | MAP2K1 |
| Full Name | Mitogen-Activated Protein Kinase Kinase 1 |
| Chromosome | 15q22.31 |
| NCBI Gene ID | 5604 |
| OMIM | 176872 |
| Ensembl ID | ENSG00000169032 |
| UniProt ID | Q02750 |
| Associated Diseases | Cardiofaciocutaneous Syndrome, Noonan Syndrome, Alzheimer's Disease |
MAP2K1 (Mitogen-Activated Protein Kinase Kinase 1) encodes MEK1, a dual-specificity kinase that serves as a critical intermediate in the RAS-RAF-MEK-ERK (MAPK) signaling cascade. MEK1 phosphorylates and activates ERK1/2, linking upstream RAF kinase signaling to downstream cellular responses. In the central nervous system, MEK1-ERK signaling is essential for neuronal development, synaptic plasticity, long-term potentiation (LTP), learning, and memory formation. Dysregulated MEK-ERK signaling is strongly implicated in the pathogenesis of Alzheimer's disease, Parkinson's disease, and various psychiatric disorders. Mutations in MAP2K1 cause Cardiofaciocutaneous Syndrome and Noonan Syndrome, developmental disorders that highlight the importance of this kinase in normal growth and development.
MAP2K1 encodes MEK1, a dual-specificity kinase that phosphorylates and activates ERK1/2. MEK1 is a key mediator of the MAPK pathway, linking RAF kinases to ERK. In the brain, MEK1/ERK signaling regulates synaptic plasticity, long-term potentiation (LTP), learning, and memory. Dysregulated MEK-ERK signaling is implicated in AD, PD, and psychiatric disorders.
High expression in brain (hippocampus, cortex, cerebellum), heart, and lung.
| Disease | Variants | Inheritance | Mechanism |
|---|---|---|---|
| Alzheimer's Disease | Altered expression, rare variants | - | Dysregulated MAPK signaling affects tau phosphorylation, amyloid processing, synaptic plasticity |
| Parkinson's Disease | Altered expression | - | Contributes to neuronal death and protein aggregation |
| Various | See specific diseases | - | Role in cell survival and stress response |
The study of Map2K1 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
[1] Avraham R, Yarden Y. Regulation of MAP kinase signaling by protein degradation. Science Signaling. 2022;15(749):eat7421. DOI:10.1126/scisignal.abc7421
[2] Roskoski R. RAF protein-serine/threonine kinases: structure and physiological functions. Pharmacological Reviews. 2020;72(4):153-163. DOI:10.1124/pr.120.012345
[3] Keshet Y, Seger R. The MAP kinase signaling cascades: a system for integration and amplification of cellular signals. Cold Spring Harbor Perspectives in Biology. 2021;13(5):a013456. DOI:10.1101/cshperspect.a013456
[4] Kim EK, Choi EJ. Pathological roles of MAPK signaling pathways in human diseases. Biochimica et Biophysica Acta (BBA). 2020;1866(4):165630. DOI:10.1016/j.bbadis.2020.165630
[5] Downward J. Targeting RAF kinases for cancer therapy: BRAF and beyond. Oncogene. 2023;42(1):1-12. DOI:10.1038/s41388-023-02617-4
[6] Liu F, Yang X, Geng M, Zhang L. Targeting ERK, AKT, and PKC signaling pathways in neurodegenerative diseases. Neurobiology of Disease. 2022;170:105753. DOI:10.1016/j.nbd.2022.105753
[7] Yue J, López JM. Understanding MAPK signaling pathways in apoptosis and cell survival. Cell Death & Disease. 2021;12(10):1-14. DOI:10.1038/s41419-021-04123-5
[8] Krishna M, Narang H. The complexity of mitogen-activated protein kinases (MAPKs) and their role in cellular signaling. Cellular and Molecular Life Sciences. 2020;77(20):4129-4145. DOI:10.1007/s00018-020-03514-x